These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37956384)

  • 21. Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring.
    Khamduang W; Gaudy-Graffin C; Ngo-Giang-Huong N; Jourdain G; Moreau A; Borkird T; Layangool P; Kamonpakorn N; Jitphiankha W; Kwanchaipanich R; Potchalongsin S; Lallemant M; Sirirungsi W; Goudeau A;
    J Clin Virol; 2013 Oct; 58(2):415-21. PubMed ID: 23916828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.
    Pan CQ; Duan Z; Dai E; Zhang S; Han G; Wang Y; Zhang H; Zou H; Zhu B; Zhao W; Jiang H;
    N Engl J Med; 2016 Jun; 374(24):2324-34. PubMed ID: 27305192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of hepatitis B immunoglobulin in prevention of mother-to-child transmission of chronic hepatitis B in HBsAg- and HBeAg-positive mother.
    Wang H; Fang JW; Gu ZW; Song DJ; Chen Y; Chen GD; Zhao B; Sun C; Ma Y; Wang KX; Shen JQ; Yang XF; Luo Q
    J Obstet Gynaecol; 2022 Jul; 42(5):877-882. PubMed ID: 34569426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus.
    Zhu B; Lv X; Zhao Z; Chen L; Chen X; Li C; Li S; Dai E
    Medicine (Baltimore); 2021 Nov; 100(44):e27695. PubMed ID: 34871254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Residual risk of mother-to-child transmission of HBV despite timely Hepatitis B vaccination: a major challenge to eliminate hepatitis B infection in Cambodia.
    E B; Ko K; Kim R; Nagashima S; Ouoba S; Hussain MRA; Sato T; Chuon C; Abe K; Sugiyama A; Takahashi K; Akita T; Tung R; Ork V; Hossain MS; Saphonn V; Tanaka J
    BMC Infect Dis; 2023 Apr; 23(1):261. PubMed ID: 37101167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG.
    Xu Q; Xiao L; Lu XB; Zhang YX; Cai X
    World J Gastroenterol; 2006 Jun; 12(21):3434-7. PubMed ID: 16733865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between hepatitis B virus serum DNA, RNA and quantitative hepatitis B surface antigen, and the predictive value for mother-to-child transmission: an observational cohort study.
    Wang C; Pan YC; Jia ZF; Chi XM; Wang YQ; Yang N; Wu YH; Niu JQ; Jiang J
    BJOG; 2022 Jan; 129(2):241-247. PubMed ID: 34455680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of hepatitis B surface and "e" antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBV.
    Boyd A; Maylin S; Gozlan J; Delaugerre C; Simon F; Girard PM; Lacombe K
    Liver Int; 2015 Mar; 35(3):795-804. PubMed ID: 24606220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice.
    Liu J; Wang J; Yan T; Du D; Qi C; Cao F; Yao N; Yang Y; He Y; Tian Z; Ren D; Zhu L; Chen T; Zhao Y
    J Viral Hepat; 2019 Oct; 26(10):1170-1177. PubMed ID: 31177596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic HBV infection among pregnant women and their infants in Shenyang, China.
    Ding Y; Sheng Q; Ma L; Dou X
    Virol J; 2013 Jan; 10():17. PubMed ID: 23294983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus.
    Lu Y; Song Y; Zhai X; Zhu F; Liu J; Chang Z; Li Y; Xiao Y; Li L; Liu M; Liu J; Duan Z; Zou H; Zhuang H; Wang J; Li J
    Emerg Microbes Infect; 2021 Dec; 10(1):555-564. PubMed ID: 33682609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large spontaneous HBV DNA fluctuations and potential usefulness of a single-point measurement of combined HBV DNA and quantitative HBsAg for the exclusion of HBeAg-negative chronic hepatitis B: A prospective Tunisian cohort study.
    Chtourou A; Gargouri S; Elleuch E; Feki L; Smaoui F; Taktak A; Mnif K; Kassis M; Hammami A; Ben Jemaa M; Karray H
    Arab J Gastroenterol; 2023 Nov; 24(4):223-229. PubMed ID: 37989673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermediate hepatitis B virus infection prevalence among 1622 pregnant women in rural Burkina Faso and implications for mother-to-child transmission.
    Ouoba S; Ko K; Lingani M; Nagashima S; Guingané AN; Bunthen E; Hussain MRA; Sugiyama A; Akita T; Ohisa M; Sanou MA; Traore O; Nassa JW; Sanou M; Takahashi K; Tinto H; Tanaka J
    Sci Rep; 2023 Apr; 13(1):6115. PubMed ID: 37059812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative HBsAg levels do not identify hepatic fibrosis in HBeAg-negative chronic hepatitis B patients.
    Ahmed FA; Bajaifar MS; Ahmed MA; Alalwan A; Sanai FA; Albeladi K; Aljumah AA; Sanai FM
    Saudi J Gastroenterol; 2019; 25(5):286-292. PubMed ID: 31044750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of hepatitis B viral loads and viral antigen levels in child-bearing age women with and without pregnancy.
    Xu C; Liu J; Liu L; Bi Y; Xu B; Chen J; Xu B; Chen T; Hu Y; Zhou YH
    BMC Pregnancy Childbirth; 2018 Jul; 18(1):292. PubMed ID: 29980185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
    Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
    BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of mother-to-child transmission of hepatitis B in relation to maternal peripartum antiviral prophylaxis: A systematic review and meta-analysis.
    Yao N; Fu S; Wu Y; Tian Z; Feng Y; Li J; Luo X; Yang Y; Ji F; Chen Y; Liu J; Zhao Y; Chen T
    Acta Obstet Gynecol Scand; 2022 Nov; 101(11):1197-1206. PubMed ID: 36082797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot integrated model nurse clinic increases the uptake of antiviral treatment for the prevention of mother-to-child transmission of HBV.
    Hui VWK; Cheung ACS; Yip ACW; Yung CCT; Mok IHY; Lau WYP; Yip TCF; Lai MSM; Lai JCT; Chan HLY; Wong VWS; Wong GLH
    Liver Int; 2024 Oct; 44(10):2583-2591. PubMed ID: 38967425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa.
    Mokaya J; Burn EAO; Tamandjou CR; Goedhals D; Barnes EJ; Andersson M; Pinedo-Villanueva R; Matthews PC
    BMC Public Health; 2019 Jun; 19(1):829. PubMed ID: 31242901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir.
    Gish RG; Chang TT; Lai CL; de Man RA; Gadano A; Llamoso C; Tang H
    Antivir Ther; 2013; 18(5):691-8. PubMed ID: 23510982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.